SDH, a novel diarylheptane compound, is a potential treatment for inflammatory bowel disease by restoring epithelial barrier function
Background: The global prevalence of inflammatory bowel disease (IBD) is increasing, and mucosal healing is the preferred treatment target of IBD. Sodium (aS,9 R)− 3-hydroxy-16,17-dimethoxy-15-oxidotricyclo[12.3.1.12,6]nonadeca-1(18),2,4,6(19),14,16-hexene-9-yl sulfate hydrate (SDH) is a novel diary...
Main Authors: | Fei Yang, Xiaoqiang Zhu, Liu Li, Yanping Wang, Qing Xie, Yu Cao, Yunhui Yu, Minjie Zhang, Dong Li, Ling Li, Zhongtian Liu, Biyan Zhang, Zijun Chen, Shiping Deng, Yunsen Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-07-01
|
Series: | Biomedicine & Pharmacotherapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0753332222004693 |
Similar Items
-
Natural Products: A Dependable Source of Therapeutic Alternatives for Inflammatory Bowel Disease through Regulation of Tight Junctions
by: Jing Peng, et al.
Published: (2023-08-01) -
Morphological manifestations of irritable bowel syndrome
by: Yu.M. Stepanov, et al.
Published: (2021-06-01) -
JAK-STAT Pathway Regulation of Intestinal Permeability: Pathogenic Roles and Therapeutic Opportunities in Inflammatory Bowel Disease
by: Hillmin Lei, et al.
Published: (2021-08-01) -
Gut Bacterial Community Determines the Therapeutic Effect of Ginsenoside on Canine Inflammatory Bowel Disease by Modulating the Colonic Mucosal Barrier
by: Aipeng Mao, et al.
Published: (2023-10-01) -
Microsporidia persistence in host impairs epithelial barriers and increases chances of inflammatory bowel disease
by: Jiangyan Jin, et al.
Published: (2024-02-01)